New weight loss drugs have captured the public's imagination but also raised existential questions about the future of bariatric surgery.August 28, 2023Check out STAT+Sponsored By GUILLERMO ARIAS/AFP via Getty Images STAT+ | What do new weight loss drugs mean for the future of bariatric surgery? New weight loss drugs have captured the public's imagination but also raised existential questions about the future of bariatric surgery. By Simar Bajaj STAT+ | Feds fine Medicare Advantage plans for overcharging their members Medicare Advantage insurers have started to be penalized for faulty technology systems that lead to people paying more than they should be. By Bob Herman ProMED issues ultimatum to striking moderators, as questions about site's future persist The site's striking moderators were told to return to work on Friday, or they will be considered to have "moved on." By Helen Branswell Listen: Housing is health care In the final episode of "Color Code" season two, we delve into how housing — and today's housing crisis — intersects with health care. By Nicholas St. Fleur Opinion: Psychiatrists like us cannot keep up with their inboxes Our new study finds a substantial increase in patient message volume to mental health professionals. But the system isn't keeping up. By Simone Bernstein and Jessica Gold STAT+ | FDA delays enforcement of a pharmaceutical supply chain law to stop counterfeit drugs As a Nov. 27, deadline for compliance approached, concern had grown that too many companies are not fully prepared to comply with the law. By Ed Silverman More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments